Avg closing price
Price range

9 AKO Capital Edwards Lifesciences Trades

The first Edwards Lifesciences trade was made in Q2 2018. Since then AKO Capital bought shares five more times and sold shares on three occasions. The investor completely sold their stake between Q1 2020 and Q2 2020.

Avg closing price
Price range
Sold -2.26 Million shares Q2 2020
Avg closing price $71.07
Price range $57.54 - $76.95
Sold 9.0% shares (-225 Thousand shares) Q1 2020
Avg closing price $72.12
Price range $52.41 - $81.00
Increased shares by 28.7% (+555 Thousand shares) Q4 2019
Avg closing price $78.09
Price range $71.70 - $82.09
Increased shares by 12.8% (+220 Thousand shares) Q3 2019
Avg closing price $70.25
Price range $61.55 - $75.43
Increased shares by 24.4% (+336 Thousand shares) Q2 2019
Avg closing price $60.47
Price range $55.74 - $64.41
Increased shares by 64.8% (+541 Thousand shares) Q1 2019
Avg closing price $57.07
Price range $47.89 - $64.05
Increased shares by 27.7% (+181 Thousand shares) Q4 2018
Avg closing price $50.60
Price range $46.41 - $56.94
Sold 10.5% shares (-76.6 Thousand shares) Q3 2018
Avg closing price $48.91
Price range $45.70 - $58.03
New holding (+730 Thousand shares) Q2 2018
Avg closing price $46.67
Price range $42.45 - $51.30

News about Edwards Lifesciences Corp and AKO Capital

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!